Barrow Neurological Institute opens major new neuroscience facility
April 19, 2022 19:36 ET
|
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center
PHOENIX, April 19, 2022 (GLOBE NEWSWIRE) -- Barrow Neurological Institute has officially opened a new neuroscience facility that is expected to serve as a national model for enhancing the patient...
Dr. Volker W. Stieber, MD, Joins Vivacitas' Neuro-Oncology Advisory Board
February 07, 2022 10:00 ET
|
Vivacitas Oncology Inc
WALNUT CREEK, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc., a privately-held biopharmaceutical company focused on tough-to-treat cancers, is proud to present Dr. Volker W....
Vivacitas Oncology Strengthens Its Neuro-Oncology Board With World-Class Advisor Dr. Katherine Peters, MD, PhD, FAAN
January 31, 2022 09:00 ET
|
Vivacitas Oncology Inc
WALNUT CREEK, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc., a privately-held biopharmaceutical company focused on tough-to-treat cancers, continues to grow its Neuro-Oncology...
Vivacitas Oncology Welcomes Dr. Jai Grewal, MD, and Expands Its Neuro-Oncology Advisory Board
January 03, 2022 09:00 ET
|
Vivacitas Oncology Inc
WALNUT CREEK, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc. ("Vivacitas" or the "Company"), a privately held oncology company focused on tough-to-treat cancers, is pleased to...
Vivacitas Oncology Presents Its New Neuro-Oncology Advisor, Dr. Andrew Lassman MD, MS, FAAN
December 15, 2021 15:00 ET
|
Vivacitas Oncology Inc
WALNUT CREEK, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc. ("Vivacitas" or the "Company"), a privately-held oncology company focused on tough-to-treat cancers, is pleased to...
Incysus Therapeutics to Present at the 2019 Society for Neuro-Oncology (SNO) Annual Meeting
November 21, 2019 07:00 ET
|
Incysus Therapeutics, Inc.
NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Sarah Durham Named Chair of the National Brain Tumor Society Board of Directors
January 10, 2019 15:47 ET
|
National Brain Tumor Society
Boston, MA, Jan. 10, 2019 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, has announced the appointment of...
Gamma-Delta (γδ) T Cell Therapy Combined With Checkpoint Inhibition Shows Potential Synergies in Vitro for Treatment of Glioblastoma
November 15, 2018 07:00 ET
|
Incysus Therapeutics, Inc.
Promising data from gamma-delta (γδ) T cell therapy in combination with checkpoint inhibitors to be presented at 2018 Society for Neuro-Oncology annual meeting NEW YORK, Nov. 15, 2018 (GLOBE...
National Brain Tumor Society Supported Work Features in 19 Presentations at 2018 Society for Neuro-Oncology Annual Meeting
November 13, 2018 16:37 ET
|
National Brain Tumor Society
Boston, MA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced that its funded...
National Brain Tumor Society Launches New Brain Tumor-Specific Clinical Trial Finder
March 22, 2017 08:30 ET
|
National Brain Tumor Society
BOSTON, MA--(Marketwired - March 22, 2017) - National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced the launch of the...